Apyx Medical Corporation Announces FDA 510(k) Clearance For Renuvion Micro Handpiece
Portfolio Pulse from Benzinga Newsdesk
Apyx Medical Corporation has received FDA 510(k) clearance for its Renuvion Micro Handpiece, a device used in minimally invasive cosmetic procedures. This approval will allow the company to expand its product offerings in the aesthetics market.
June 14, 2023 | 11:32 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Apyx Medical Corporation's FDA 510(k) clearance for Renuvion Micro Handpiece is expected to have a positive short-term impact on the company's stock price.
The FDA 510(k) clearance for Apyx Medical Corporation's Renuvion Micro Handpiece is a significant milestone for the company. This approval will allow Apyx to expand its product offerings in the aesthetics market, which could lead to increased revenues and growth. As a result, the stock price is likely to experience a positive short-term impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100